Case
Case
The American pharmaceutical company, Zevra Therapeutics, has chosen Denmark as its first country in Europe to expand its activities and to tap into the Danish life science cluster for pioneering R&D. Zevra Therapeutics acquired the drug in development, Arimoclomol, from Orphazyme, and retains the R&D activities in Denmark.
When
In May 2022, pharmaceutical company Zevra Therapeutics reached a definitive agreement with the Danish biotech company Orphazyme to acquire its sole experimental candidate, Arimoclomol. Zevra Therapeutics intends to retain the majority of Orphazyme’s current employees in pursuit of an approval of Arimoclomol as a treatment for NPC (Niemann-Pick disease type C).
The acquisition of Arimoclomol is a strategic decision from Zevra Therapeutics to expand its pipeline of treatments for rare central nervous system (CNS) diseases. Denmark’s biotech and pharma cluster has a global reputation for cutting-edge research, particularly in CNS, cancer, inflammatory and infectious diseases. With the new Danish entity, Zevra Therapeutics has gained access to a hotspot for pioneering research and development as well as a world-class infrastructure for testing new medical treatments. Denmark has a strategic focus on offering the best conditions for R&D, including clinical trials. The continuous optimization and governmental commitment to clinical trials in Denmark make it increasingly favourable for a company such as Zevra Therapeutics.
Chief Financial Officer of Zevra Therapeutics, LaDuane Clifton, already sees a big potential in the Danish entity for accessing European research and development activities and is hoping to expand Zevra Therapeutics’s presence in Denmark.
“We are thrilled to be part of Denmark’s thriving life science sector that has established a reputation for cutting edge research, particularly in the central nervous system. The acquisition of arimoclomol aligns perfectly with our strategy to build Zevra Therapeutics’s value via the advancement and commercialization of novel treatments that address rare CNS conditions, including our lead clinical candidate, KP1077 in idiopathic hypersomnia.”LaDuane Clifton
Chief Financial Officer of Zevra Therapeutics
Zevra Therapeutics is a pharmaceutical company headquartered in Florida, USA, focused on discovery, development and commercialization of novel treatments for rare central nervous system (CNS) and neurodegenerative diseases, liposomal storage disorders and related treatment areas. Founded in 2006, Zevra Therapeutics has offices in several locations across the US. The acquisition of Orphazyme’s activities is the first international expansion.
Niemann-Pick is a rare, progressive and inherited disease that affects the body's ability to metabolize fat (cholesterol and lipids) within cells.
Invest in Denmark has assisted Zevra Therapeutics with information on the Danish life science ecosystem, establishing contact to relevant service providers and helped understand business and framework conditions. Invest in Denmark is in continuous dialogue with Zevra Therapeutics in order to inform about opportunities within the CNS space in Denmark.
“We are excited to welcome Zevra Therapeutics to Denmark and to see the activities of Orphazyme sustained within the borders of Denmark. Zevra Therapeutics is a great addition to our ecosystem and will contribute to make the Danish life science cluster one of the strongest in the world.”Anne Hougaard
Director at Invest in Denmark
We provide free-of-charge confidential and tailor-made solutions for foreign companies looking to set up a new business in Denmark or expand an existing one. Please contact one of our experts here:
Title: Director
Area: Copenhagen
Email: [email protected]
Phone: +4533921195
Title: Deputy Director
Area: Copenhagen
Email: [email protected]
Phone: +4521836195
Title: Director for Europe
Area: Copenhagen
Email: [email protected]
Phone: +45 6197 9220
Title: Team Leader - Life Sciences & Food
Area: Copenhagen
Email: [email protected]
Phone: +45 3392 1350
Title: Team Leader - Cleantech
Area: Copenhagen
Email: [email protected]
Phone: +4533920836
Title: Team Leader, Tech
Area: Copenhagen
Email: [email protected]
Phone: +4533921736
Title: Team Leader - Analysis & Partnership
Area: Copenhagen
Email: [email protected]
Phone: +4533921093
Title: Special Advisor - Life Sciences
Area: Copenhagen
Email: [email protected]
Phone: +4521247056
Title: Special Advisor – Maritime and transport – Analysis & Partnerships
Area: Copenhagen
Email: [email protected]
Phone: +4533920423
Title: Special Advisor - Cleantech
Area: Copenhagen
Email: [email protected]
Phone: +4533920810
Title: Special Advisor - Quantum Tech & Venture Capital
Area: Copenhagen
Email: [email protected]
Phone: +45 2938 9943
Title: Special Advisor – Dual-use tech
Area: Copenhagen
Email: [email protected]
Phone: +45 2133 8147
Title: Special Advisor - Analysis & Partnerships
Area: Copenhagen
Email: [email protected]
Phone: +4533921639
Title: Digital Marketing Specialist
Area: Copenhagen
Email: [email protected]
Title: Special Advisor - Quantum Tech
Area: Copenhagen
Email: [email protected]
Phone: +4533920783
Title: Special Advisor - Life Sciences & Biosolutions
Area: Copenhagen
Email: [email protected]
Phone: +45 40 25 69 08
Title: Project Assistant – Analysis & Partnerships
Area: Copenhagen
Email: [email protected]
Phone: +4533920535
Title: Project Assistant - Tech
Email: [email protected]
Phone: +4533921916
Title: Life Science Production Coordinator
Area: Berlin
Email: [email protected]
Phone: +49 3050502140
Title: Special Advisor - Logistics, Distribution & Production
Area: Kolding
Email: [email protected]
Phone: +45 5144 8613
Title: Special Advisor - Cleantech
Area: Silkeborg
Email: [email protected]
Phone: +45 2170 5851
Title: Special Advisor - Food
Area: Aarhus
Email: [email protected]
Phone: +45 2383 4608
Title: Special Advisor - Tech
Area: Aarhus
Email: [email protected]
Phone: +45 2051 7594
Title: Special Advisor - Life Sciences
Area: Aarhus
Email: [email protected]
Phone: +45 2856 8540
Title: Special Advisor – Cleantech & ICT
Area: Aalborg
Email: [email protected]
Phone: +45 6010 6101
Title: Special Advisor - ICT & Cleantech
Area: Aalborg
Email: [email protected]
Phone: +45 4115 3125
Title: Investment Manager
Area: Oslo
Email: [email protected]
Phone: +47 9132 2010
Title: Investment manager – Tech & Quantum
Area: London
Email: [email protected]
Phone: +44 (0) 78 1083 7296
Title: Senior Investment Manager - Cleantech & Life Sciences
Area: London
Email: [email protected]
Phone: +44 (0) 20 7333 0218
Title: Investment Manager – Life Sciences & Food
Area: London
Email: [email protected]
Phone: +44 7511 877225
Title: Investment Manager – Life Sciences & Food
Area: Paris
Email: [email protected]
Phone: +33 (0) 6 72 32 40 82
Title: Investment Manager - Cleantech
Area: Paris
Email: [email protected]
Phone: +33632637658
Title: Investment Manager - Tech
Area: Munich
Email: [email protected]
Phone: +498954585425
Title: Investment Manager – Tech
Area: New York
Email: [email protected]
Phone: +1 (929) 726-9167
Title: Investment manager - Cleantech
Area: New York
Email: [email protected]
Title: Investment Manager - Life Sciences
Area: New York
Email: [email protected]
Phone: +1 (212) 7054946
Title: Director for North America
Area: New York
Email: [email protected]
Phone: +1 (212) 705 4972
Title: Deputy Director, North America & Senior Investment Manager - Life Sciences & Location Denmark
Area: New York
Email: [email protected]
Phone: +1 (917) 497 1300
Title: Investment Manager - Food & Location Denmark
Area: New York
Email: [email protected]
Phone: +1 (212) 705 4928
Title: Life Science Production Coordinator – Life Sciences
Area: New York
Email: [email protected]
Phone: +1 (212) 705-4974
Title: Investment Manager – CleanTech, Life Science & Food
Area: Canada
Email: [email protected]
Phone: +1 647 295 5704
Title: Investment Manager - Tech
Area: Toronto
Email: [email protected]
Phone: +1 (416) 565-0248
Title: Investment Manager - Life Science & Digital Health
Area: Silicon Valley
Email: [email protected]
Phone: +1 (650) 272-9510
Title: Investment Manager - Cleantech
Area: Silicon Valley
Email: [email protected]
Title: Investment Manager - Quantum Technology
Area: Tokyo
Email: [email protected]
Phone: +818040006915
Title: Investment Manager – Life Science & Food
Area: Tokyo
Email: [email protected]
Phone: +81 3 3496 3001
Title: Investment Manager
Area: Tokyo
Email: [email protected]
Phone: +81337808745
Title: Investment Manager - Cleantech & ICT
Area: Bangalore
Email: [email protected]
Phone: +91 963 234 2021
Title: Investment Manager – Tech
Area: Bangalore
Email: [email protected]
Phone: +91 91088 19810
Title: Investment Manager - Tech, Life Sciences & Cleantech
Area: Taipei
Email: [email protected]
Phone: +886 968 309 526
Title: Head of Marketing & Communication, Asia
Area: Shanghai
Email: [email protected]
Phone: +86 21 8025 0642
Title: Investment Manager - Cleantech & Maritime
Area: Shanghai
Email: [email protected]
Phone: +86 158 0058 0725
Title: Senior Investment Manager - Location Denmark & Life Sciences
Area: Shanghai
Email: [email protected]
Phone: +86 21 8025 0636
Title: Director for Asia
Area: Singapore
Email: [email protected]
Phone: +6565060277
Title: Investment Manager in Cleantech, Tech, Life Science, Food & Maritime
Area: Singapore
Email: [email protected]
Phone: +65 8028 3668
